Government of Spain

Five Prime Therapeutics to Participate in the Cowen 41st Annual Health Care Conference

Friday, February 26, 2021 - 10:00pm

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m.

Key Points: 
  • Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer are scheduled to participate in a fireside chat at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021 at 10:30 a.m.
  • Live audio webcast of the presentation will be accessible and available for replay from the Events & Presentations section of the Companys website at: http://investor.fiveprime.com/events.cfm .
  • Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.
  • Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ebix, Inc. (EBIX)

Friday, February 26, 2021 - 5:30pm

Investors suffering losses on their Ebix investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .

Key Points: 
  • Investors suffering losses on their Ebix investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Getty Realty Corp. Announces Retirement of Chairman & Co-Founder Leo Liebowitz

Friday, February 26, 2021 - 12:30pm

Getty Realty Corp. (NYSE:GTY) announced today that Leo Liebowitz, the Companys Chairman & Co-Founder has elected to retire from the Board of Directors, effective February 23, 2021.

Key Points: 
  • Getty Realty Corp. (NYSE:GTY) announced today that Leo Liebowitz, the Companys Chairman & Co-Founder has elected to retire from the Board of Directors, effective February 23, 2021.
  • Mr. Liebowitzs decision to retire comes after more than 50 years of service as the Companys Chairman of the Board.
  • In addition to his tenure as the Companys Chairman, he served as our Chief Executive Officer from 1985 until 2010 and as our President from 1971 until 2004.
  • Mr. Liebowitz co-founded the Company through the acquisition of a single gas station in New York City in 1955.

Sabra Health Care REIT, Inc. to Attend Citi’s Global Property CEO Conference

Thursday, February 25, 2021 - 9:05pm

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the companys Chairman and Chief Executive Officer, Harold Andrews, the companys Chief Financial Officer, Talya Nevo-Hacohen, the companys Chief Investment Officer, and Michael Costa, the companys Executive Vice President of Finance and Chief Accounting Officer, will attend Citis Global Property CEO Conference on March 8 11, 2021.

Key Points: 
  • Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the companys Chairman and Chief Executive Officer, Harold Andrews, the companys Chief Financial Officer, Talya Nevo-Hacohen, the companys Chief Investment Officer, and Michael Costa, the companys Executive Vice President of Finance and Chief Accounting Officer, will attend Citis Global Property CEO Conference on March 8 11, 2021.
  • Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20210225006059/en/

Strongbridge Biopharma plc to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call on March 3, 2021

Thursday, February 25, 2021 - 12:30pm

ET to discuss the Companys fourth quarter and full-year 2020 financial results and corporate highlights.

Key Points: 
  • ET to discuss the Companys fourth quarter and full-year 2020 financial results and corporate highlights.
  • The conference call will follow the anticipated release of the Companys financial results earlier that day.
  • Strongbridge will host a conference call on Wednesday, March 3, 2021 at 8:30 a.m.
  • Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.

Enerflex Announces Fourth Quarter 2020 Financial Results and Quarterly Dividend

Wednesday, February 24, 2021 - 10:02pm

During the quarter, the Company finalized the extensions of two BOOM contracts for an additional 10 years, as previously announced in the second quarter of 2020.

Key Points: 
  • During the quarter, the Company finalized the extensions of two BOOM contracts for an additional 10 years, as previously announced in the second quarter of 2020.
  • As such, the Company has recorded these contracts as finance leases in fourth quarter results.
  • Subsequent to December 31, 2020, Enerflex declared a quarterly dividend of $0.02 per share, payable on April 1, 2021, to shareholders of record on March 11, 2021.
  • The Companys results include items that are unique and items that management and users of the financial statements adjust for when evaluating the Companys results.

Guardian Capital Group Limited (TSX: GCG; GCG.A) Announces Operating Results for the Year Ended December 31, 2020

Wednesday, February 24, 2021 - 9:37pm

The Companys Operating earnings in the current year were $54.8 million, an increase of $5.9 million, or 12%, from $48.9 million reported in 2019.

Key Points: 
  • The Companys Operating earnings in the current year were $54.8 million, an increase of $5.9 million, or 12%, from $48.9 million reported in 2019.
  • The largest growth in 2020 Operating earnings came from GuardCap, our UK-based investment management business, and IDC WIN, our life insurance managing general agency business.
  • The Companys AUA were $22.3 billion as at December 31, 2020, compared to $20.2 billion at the end of 2019.
  • The Companys Net earnings attributable to shareholders in 2020 were $42.4 million, compared to $123.1 million in 2019.

EpiEndo Pharmaceuticals Appoints Maria Bech as New Chief Executive Officer to Support Move into Clinical Development

Wednesday, February 24, 2021 - 2:23pm

The Board of EpiEndo Pharmaceuticals is pleased to announce the appointment of Maria Bech, MSc as Chief Executive Officer (CEO) of the Company, effective immediately.

Key Points: 
  • The Board of EpiEndo Pharmaceuticals is pleased to announce the appointment of Maria Bech, MSc as Chief Executive Officer (CEO) of the Company, effective immediately.
  • Prof Clive Page OBE, Chairman of the Board of EpiEndo Pharma welcomed the appointment: I am delighted to welcome Maria into this new role as CEO.
  • Im honoured to be leading the advancement of the companys innovative drug science into this next phase of clinical development.
  • Ms Bech who transitions into the role, had previously been engaged to supervise the EpiEndos clinical development strategy and preparation of the Companys first in man study.

Medexus Schedules Third Quarter Fiscal 2021 Conference Call

Wednesday, February 24, 2021 - 2:00pm

TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the Company or Medexus) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, March 2, 2021 to discuss the Companys financial results for the fiscal 2021 third quarter ended December 31, 2020, as well as the Companys corporate progress and other developments.

Key Points: 
  • TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the Company or Medexus) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)today announced that it plans to host a conference call at 8:00 AM Eastern Time on Tuesday, March 2, 2021 to discuss the Companys financial results for the fiscal 2021 third quarter ended December 31, 2020, as well as the Companys corporate progress and other developments.
  • The Company expects to file its financial statements along with its MD&A post market on March 1, 2021.
  • The conference call will be available via telephone by dialing toll free 888-506-0062 for Canadian and U.S. callers or +1 973-528-0011 for international callers and using entry code 414918.
  • A webcast replay will be available on the Companys Investor Events section of the website ( https://www.medexus.com/en_US/investors/news-events ) through Wednesday, June 2, 2021.

Domtar Corporation Announces Management Committee Appointments

Wednesday, February 24, 2021 - 1:30pm

Domtar Corporation (NYSE: UFS) (TSX: UFS) today announced appointments to the companys management committee.

Key Points: 
  • Domtar Corporation (NYSE: UFS) (TSX: UFS) today announced appointments to the companys management committee.
  • These appointments streamline and simplify the companys management structure and will help advance Domtars strategic plan to lower costs and refocus the companys portfolio on paper, pulp and packaging.
  • Brennan has 29 years of supply chain expertise and has been with Domtar for over six years.
  • Appointments of the following two leaders to the Management Committee will take effect on April 2.